New Research Highlights Importance of Enhanced Cancer Screening for Women with Dense Breasts
Recent findings indicate that additional cancer screenings for women with extremely dense breast tissue could potentially save hundreds of lives annually.
While millions of women participate in breast screening, regular mammograms tend to miss cancer detection in about 10% of cases involving very dense breasts. This occurs because the dense tissue can obscure tumors in x-ray images. Essentially, very dense breasts appear white on scans, which complicates early disease detection.
Researchers from the University of Cambridge assert that implementing enhanced screening options for these women may allow for the identification of 3,500 cancer cases each year, ultimately preventing 700 deaths annually in the UK. This research was detailed in The Lancet.
Professor Fiona Gilbert, leading the study, mentioned, “Early cancer diagnosis significantly impacts patient care and long-term outcomes. We need to update our national screening programs to ensure that more cancers are identified sooner, giving more women a better chance at survival.”
She further noted, “While this study specifically addresses the UK’s breast cancer screening approach, its implications extend globally to all nations that utilize similar screening methods for women with dense breast tissue.”
The investigation surveyed 9,361 women in the UK with high breast density who had previously received negative mammogram results. By employing additional scanning techniques, the researchers discovered an extra 85 cancer instances.
Two of the enhanced methods examined were contrast-enhanced mammography (CEM), which improves visibility of blood vessels through the use of dyes, and automated breast MRI (AB-MRI), which offers quicker assessments compared to traditional MRI.
The findings suggested that incorporating either of these advanced techniques into existing screening protocols could allow for the detection of 3,500 cancers annually in the UK. The Cambridge team estimates that a reduction in mortality rates for about 20% of the identified cancers could lead to saving around 700 lives each year.
The trial also explored a third method—automatic breast ultrasound (ABUS)—but found it significantly less effective than CEM and AB-MRI.
Specifically, CEM identified 19 cancers per 1,000 women screened, AB-MRI found 17, while ABUS detected just 4. Currently, routine mammograms already catch about eight cases of cancer per 1,000 women with dense breast tissue, so adding extra scans could potentially exceed the current detection rates.
Funded by Cancer Research UK (CRUK) and with support from the National Institutes of Health and Cambridge Center for Biomedical Research, the trials highlighted how these scans can identify additional small cancers that may be life-saving. However, more research is necessary to ascertain whether this would reduce cancer-related deaths and to evaluate the risks of overdiagnosis alongside the cost-benefit ratio of implementing additional scans.
Dr. David Crosby, director of CRUK’s prevention and early detection, remarked, “Gaining a full understanding of the effectiveness of these technologies necessitates further investigation, but the results so far are promising.”
In response, Dr. Kotorina Temsinite, director of breast cancer research and community involvement, urged, “The UK National Screening Committee should consider this research during their current review on whether women with extremely dense breast tissue should be offered additional imaging during routine screenings.”
She added, “We recognize that standard breast screening is not very reliable in pinpointing cancers in dense tissue when treatment is most likely to be effective, yet we strongly advocate for all women to participate in mammogram screenings when invited.”
A representative from the Ministry of Health’s Ministry of Social Care stated that research focused on intensive scans for women with dense breast tissue is underway as part of the NHS breast screening initiative. “The UK National Screening Committee will take this evidence into account as it becomes available,” the spokesperson concluded.
